Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study

Abstract

Objective

To investigate the characteristics and associated factors of invasive fungal disease in patients with systemic lupus erythematosus from Southern China.

Methods

A retrospective study was performed. Demographic and clinical characteristics, laboratory data, and radiographic manifestations were recorded.

Results

A total of 45 lupus patients with invasive fungal disease (incidence 1.1%) were included. Twenty-three cases (51.1%) were infected with mold and 22 cases (48.9%) with yeast. Aspergillus spp. (44.4%) and Cryptococcus spp. (33.3%) were common. Aspergillosis mainly occurred in the lung. Cryptococcosis developed in the lung (40.0%), meninges (46.7%) and bloodstream (13.3%). Compared with yeast infection, mold infection tended to develop in patients with active lupus nephritis (65.2% vs. 31.8%, P = 0.03) and the mortality rate was higher (20.0% vs. 0%, P = 0.001). Co-infection with bacteria, virus or superficial fungi occurred in 12 patients (26.7%). Multivariate logistic regression analysis indicated that lymphopenia (odds ratio 2.65, 95% confidential interval 1.14–6.20, P = 0.02) and an accumulated dose of glucocorticoid (odds ratio 1.58, 95% confidence interval 1.10–2.25, P = 0.01) was associated with invasive fungal disease in lupus patients.

Conclusion

Mold infection tended to develop in patients with active lupus disease with high mortality. Co-infection is not rare. Lymphopenia and an accumulated dose of glucocorticoid are associated with invasive fungal disease in lupus patients.

Keywords

Systemic lupus erythematosus invasive fungal disease lymphopenia co-infection

Get full access to this article

View all access options for this article.

References

Cervera

Khamashta

Font

, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299–308.

Goldblatt

Chambers

Rahman

Isenberg

. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 2009; 18: 682–689.

Jakes

Bae

Louthrenoo

Mok

Navarra

Kwon

. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res Hoboken 2012; 64: 159–168.

Busca A, Passera R, Maffini E, et al. Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting. Bone Marrow Transplant 2018; 53: 1304–1310.

Patel

Vanikar

, et al. Invasive fungal infections in renal transplant patients: a single center study. Ren Fai 2017; 39: 294–298.

Cuchacovich

Gedalia

. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am 2009; 35: 75–93.

Chen

Zhu

. Invasive fungal infection in Chinese patients with systemic lupus erythematosus. Clin Rheumatol 2012; 31: 1087–1091.

Martínez-Martínez

Herrera-Van Oosdam

Roman-Acosta

, et al. Invasive fungal infections in patients with systemic lupus erythematosus. J Rheumatol 2012; 39: 1814–1818.

Silva

Ferriani

Terreri

, et al. A multicenter study of invasive fungal infections in patients with childhood-onset systemic lupus erythematosus. J Rheumatol 2015; 42: 2296–2303.

10.

Kurosaki

Bando

Nakayama

, et al. Clinical features of pulmonary aspergillosis associated with interstitial pneumonia. Intern Med 2014; 53: 1299–1306.

11.

Kotani

Takeuchi

Makino

, et al. Efficacy and safety of liposomal amphotericin B for deep mycosis in patients with connective tissue disease. J Infect Chemother 2013; 19: 691–697.

12.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

13.

De Pauw

Walsh

Donnelly

, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses. Clin Infect Dis 2008; 46: 1813–1821.

14.

Chen

Xie

Chen

, et al. Infection in Southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol 2016; 43: 1650–1666.

15.

Bombardier

Gladman

Urowitz

Caron

Chang

. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–640.

16.

Wang

Barber

Johnson

Barnabe

. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum 2014; 44: 325–330.

17.

Fang

Chen

Liu

, et al. Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review. Emerg Microbes Infect 2016; 5: e95.

18.

Pappas

Alexander

Andes

, et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET). Clin Infect Dis 2010; 50: 1101–1111.

19.

Singh

Hossain

Kotb

Wells

. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med 2016; 14: 137.

20.

Rúa-Figueroa

López-Longo

Galindo-Izquierdo

, et al. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum 2017; 47: 38–45.

21.

González-Naranjo

Betancur

Alarcón

, et al. Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: data from a multiethnic Latin American cohort. Semin Arthritis Rheum 2016; 45: 675–683.

22.

Lieberman

Tsokos

. Lupus-prone mice fail to raise antigen-specific T cell responses to intracellular infection. PLoS One 2014; 9: e111382.

23.

Wuthrich

Deepe

Klein

. Adaptive immunity to fungi. Annu Rev Immunol 2012; 30: 115–148.

24.

Leibundgut-landmann

Wothrich

Hohl

. Immunity to fungi. Curr Opin Immunol 2012; 24: 449–458.

25.

Perruccio

Tosti

Burchielli

, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 2005; 106: 4397–4406.

26.

Danza

Ruiz-Irastorza

. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 2013; 22: 1286–1294.

27.

Ruiz-Irastorza

Olivares

Ruiz-Arruza

Martinez-Berriotxoa

Egurbide

Aguirre

. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther 2009; 11: R109.

28.

Feldman

Hiraki

Winkelmayer

, et al. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol 2015; 67: 1577–1585.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.18 MB